Page last updated: 2024-08-23

tetrahydrocannabivarin 9 and Schizophrenia

tetrahydrocannabivarin 9 has been researched along with Schizophrenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cascio, MG; Marini, P; Parolaro, D; Pertwee, RG; Zamberletti, E1

Other Studies

1 other study(ies) available for tetrahydrocannabivarin 9 and Schizophrenia

ArticleYear
The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects.
    British journal of pharmacology, 2015, Volume: 172, Issue:5

    Topics: Animals; Antipsychotic Agents; Cannabinoids; CHO Cells; Cricetulus; Dronabinol; Male; Molecular Sequence Data; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Schizophrenia; Schizophrenic Psychology

2015